LBA25 FRESCO-2: A global phase III multiregional clinical trial (MRCT) evaluating the efficacy and safety of fruquintinib in patients with refractory metastatic colorectal cancer

Autor: N.A. Dasari, S. Lonardi, R. Garcia-Carbonero, M.E. Elez Fernandez, T. Yoshino, A.F. Sobrero, J.C. Yao, P. García-Alfonso, J. Kocsis, A. Cubillo Gracian, A. Sartore Bianchi, T. Satoh, V. Randrian, J. Tomasek, G. Chong, Z. Yang, W. Schelman, M. Kania, J. Tabernero, C. Eng
Rok vydání: 2022
Předmět:
Zdroj: Annals of Oncology. 33:S1391-S1392
ISSN: 0923-7534
Databáze: OpenAIRE